Tumor Growth Rate Informs Treatment Efficacy in Metastatic Pancreatic Adenocarcinoma: Application of a Growth and Regression Model to Pivotal Trial and Real-World Data

Yeh, C., Zhou, M., Sigel, K., Jameson, G., White, R., Safyan, R., Saenger, Y., Hecht, E., Chabot, J., Schreibman, S., Juzyna, B., Ychou, M., Conroy, T., Fojo, T., Manji, G. A., Von Hoff, D., & Bates, S. E. (2022). Tumor Growth Rate Informs Treatment Efficacy in Metastatic Pancreatic Adenocarcinoma: Application of a Growth and Regression Model to Pivotal Trial and Real-World Data. The Oncologist, 28(2), 139–148. https://doi.org/10.1093/oncolo/oyac217
Authors:
Celine Yeh
Mengxi Zhou
Keith Sigel
Gayle Jameson
Ruth White
Rachael Safyan
Yvonne Saenger
Elizabeth Hecht
John Chabot
Stephen Schreibman
Béata Juzyna
Marc Ychou
Thierry Conroy
Tito Fojo
Gulam A Manji
Daniel Von Hoff
Susan E Bates
Affiliated Authors:
Celine Yeh
Mengxi Zhou
Ruth White
Rachael Safyan
Yvonne Saenger
John Chabot
Stephen Schreibman
Tito Fojo
Gulam A Manji
Susan E Bates
Author Keywords:
pancreatic cancer
tumor growth rate
survival biomarkers
Publication Type:
Article
Unique ID:
10.1093/oncolo/oyac217
PMID:
Journal:
Publication Date:
Data Source:
PubMed

Record Created: